SECsense Logo

Inmune Bio Inc. 8-K Report: Key Insights for Investors (Feb 2025)

$INMB
Form 8-K
Filed on: 2025-02-10
Source
Inmune Bio Inc. 8-K Report: Key Insights for Investors (Feb 2025)

Based on the provided section of the financial report, here are the key pieces of information extracted:

  1. Company Identification:
  • Name: Inmune Bio Inc.
  • CIK (Central Index Key): 0001711754
  • SEC File Number: 001-38793
  • Tax ID: 47-5205835
  • Address: 225 NE Mizner Blvd. Suite 640, Boca Raton, FL 33432
  • Phone Number: 858-964-3720
  1. Filing Details:
  • Filing Type: 8-K
  • Filing Date: February 6, 2025
  1. Stock Information:
  • Stock Type: Common Stock
  • Par Value: $0.001 per share
  • Stock Symbol: INMB
  • Exchange: NASDAQ
  1. Financial Context:
  • Report Date: As of February 6, 2025
  • Currency: USD (United States Dollars)
  1. Units of Measurement:
  • The report uses multiple units of measurement including USD for currency and shares for stock.

Insights:

  • The report is a current report (8-K), which typically indicates that it contains significant information that shareholders should be aware of, such as key events, changes, or financial performance updates.
  • The presence of detailed identifiers such as CIK and SEC file number suggests compliance with SEC regulations, which is crucial for transparency and credibility.
  • The company's listing on NASDAQ indicates it is publicly traded, which is important for investors looking at liquidity and market access.

This information would be critical for investors, analysts, and stakeholders looking to understand Inmune Bio Inc.'s current status and any significant events that may impact its operations or stock performance.